Omega 3 fatty acids and GPR120 - PubMed (original) (raw)

Review

Omega 3 fatty acids and GPR120

Da Young Oh et al. Cell Metab. 2012.

Abstract

Human loss-of-function gene variants in GPR120 have recently been identified that confer increased risk for obesity and metabolic syndrome. In addition, GPR120 KO mice develop obesity, increased inflammation, and insulin resistance, consistent with a role for GPR120 signaling in the metabolic syndrome and diabetes mellitus.

Copyright © 2012 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1. [LS1]GPR120 Is an ω3-FA Receptor/Sensor, and Loss of Function Leads to Obesity and Insulin Resistance

A small fraction (∼3%) of obese[LS2] carry a loss-of-function, nonsynonymous GPR120 variant (R270H) that exhibits impaired intrinsic signaling properties and inhibits ω3-FA stimulation of WT GPR120. In European populations, this variant is associated with increased risk for obesity and insulin resistance, and high-fat-fed GPR120 KO mice also develop obesity and insulin resistance.

References

    1. Cintra DE, Ropelle ER, Moraes JC, Pauli JR, Morari J, Souza CT, Grimaldi R, Stahl M, Carvalheira JB, Saad MJ, Velloso LA. PLoS ONE. 2012;7:e30571. - PMC - PubMed
    1. Facchini FS, Hua N, Abbasi F, Reaven GM. J Clin Endocrinol Metab. 2001;86:3574–3578. - PubMed
    1. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, et al. Nature. 2012;483:350–354. - PubMed
    1. Kahn SE, Hull RL, Utzschneider KM. Nature. 2006;444:840–846. - PubMed
    1. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. Cell. 2010;142:687–698. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources